Monash IVF Group Limited (ASX: MVF)
Australia
· Delayed Price · Currency is AUD
1.130
-0.010 (-0.88%)
Nov 21, 2024, 4:10 PM AEST
Monash IVF Group Revenue
In the fiscal year ending June 30, 2024, Monash IVF Group had annual revenue of 255.23M AUD with 19.38% growth. Monash IVF Group had revenue of 129.52M in the half year ending June 30, 2024, with 41.83% growth.
Revenue
255.23M
Revenue Growth
+19.38%
P/S Ratio
1.73
Revenue / Employee
255.99K
Employees
997
Market Cap
440.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 255.23M | 41.43M | 19.38% |
Jun 30, 2023 | 213.80M | 21.50M | 11.18% |
Jun 30, 2022 | 192.29M | 8.69M | 4.73% |
Jun 30, 2021 | 183.61M | 38.19M | 26.26% |
Jun 30, 2020 | 145.42M | -6.56M | -4.32% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Ramsay Health Care Limited | 16.66B |
Telix Pharmaceuticals Limited | 645.68M |